NERLANDE JOASIL: Open Payments
NPI 1952673535 · CEDAR KNOLLS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 48 payments from 13 companies in 2025. Trend: 2023 $783 · 2024 $1,079 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $218 |
| ABBVIE INC. | 11 | $149 |
| Corcept Therapeutics | 4 | $83 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Lilly USA, LLC | 3 | $56 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
Products named: Ozempic, Korlym, VRAYLAR, QULIPTA, MOUNJARO, SHINGRIX, Wegovy, NEFFY.
Industry payments across NJ — which companies pay providers there.
